News Center

Home page

Peak Report

News reports

Announcement on the Resolution of the Ten Session of the Board of Directors

Release time:

2020-08-05

Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-040

Bond Abbreviation: 13 Peak 01 Bond Code: 122227

Bond Abbreviation: 13 Peak 02 Bond Code: 122344

Zhejiang Jianfeng Group Co., Ltd.

Tenth Session of the First Board of Directors Resolution Announcement

The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .

1. Board Meeting

(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.

(II) 2017# On November 5, 28, the company issued the notice of the board meeting by fax, e-mail and personal service.

(III) 2017# On November 16, 31, the board meeting was held in the conference room on the third floor of Jianfeng Building, Jinhua City, Zhejiang Province by a combination of on-site and fax voting.

(IV) 9

directors who should attend this board meeting, 9 directors who actually attended the meeting, and 9 valid votes at the meeting.

Deliberation of 2. Board Meeting

(I) "Proposal on Election of Chairman"

After deliberation and voting, the board of directors passed the proposal.

elected Mr. Jiang Xiaomeng as the chairman of the 10th board of directors of the company, and his term of office will expire until the 10th board of directors.

The result of the vote was: 9

votes in favor, 0 votes against, and 0 abstentions.

(II) "Proposal on Election of Special Committees of the Board of Directors"

After deliberation and voting, the board of directors passed the proposal.

elected Mr. Jiang Xiaomeng, Mr. Du Zihong, Mr. Huang Sujian, Mr. Sun Hongbin and Mr. Shi Ximin as members of the Strategy Committee of the 10th Board of Directors, and Mr. Jiang Xiaomeng, Chairman of the Board of Directors, as Chairman of the Strategy Committee.

elected Mr. Shi Ximin, Mr. Huang Congyun, and Mr. Jiang Xiaomeng as members of the Audit Committee of the 10th Board of Directors, and Mr. Shi Ximin as the chairman.

elected Mr. Sun Hongbin, Mr. Huang Congyun, and Mr. Jiang Xiaomeng as members of the Nomination Committee of the 10th Board of Directors, and Mr. Sun Hongbin as the chairman.

Mr. Huang Congyun, Mr. Shi Ximin and Mr. Du Zihong were elected as members of the Remuneration and Evaluation Committee of the 10th Board of Directors, and Mr. Huang Congyun was elected as the chairman.

Voting Results: 9

votes in favor, 0 votes against, 0 abstentions.

(III) "Proposal on Appointment of General Manager"

After deliberation and voting, the board of directors passed the proposal.

Mr. Yu Jianhong was appointed as the general manager of the company until the expiration of the 10th board of directors. The resume is attached.

Voting result: 9

votes in favor, 0 votes against and 0 abstentions.

(IV) "Proposal on Appointment of Secretary of Board of Directors"

After deliberation and voting, the board of directors passed the proposal.

Mr. Zhu Jianwei was appointed as the secretary of the board of directors of the company until the expiration of the 10th board of directors. The resume is attached. Voting result of

: 9

votes in favor, 0 votes against and 0 abstentions.

(V) "Proposal on Appointment of Deputy General Manager and Chief Financial Officer"

After deliberation and voting, the board of directors passed the proposal.

Mr. Huang Jinlong, Mr. Zhang Fengliang, and Mr. Xiang Chongping were appointed as the company's deputy general managers, and Mr. Lan Xiaolong was appointed as the company's financial officer. The term of office will expire until the tenth board of directors. The resume is attached. Voting result of

: 9

votes in favor, 0 votes against and 0 abstentions.

(VI) "Proposal on Appointment of Director of Audit Office and Securities Affairs Representative"

After deliberation and voting, the board of directors passed the proposal.

Appointed Ms. Liu Lisu as the director of the company's audit office, and Mr. Zhou Hengbin as the company's securities affairs representative. The term of office will expire until the tenth board of directors. The resume is attached.

Voting Results: 9

votes in favor, 0 votes against, 0 abstentions.

The three independent directors of the company expressed their independent opinions on the above proposal, and believed that the educational background and work experience of all the personnel appointed by the board of directors met the job requirements, and there was no situation stipulated in Article 147 of the Company Law. And the phenomenon that the China Securities Regulatory Commission has determined that the market ban has not been lifted. The nomination and appointment procedures of the above-mentioned personnel comply with the relevant provisions of the Company Law and the company's Articles, there is no harm to the interests of small and medium shareholders.

3. Internet Announcement Annex

, the opinions of the 10th independent director of the company on the above related matters.

hereby announces

Zhejiang Jianfeng Group Co., Ltd. Board of Directors

November 16, 2017

Attached: Resume

, Mr. Yu Jianhong: 1966# born in October 117, senior economist, engineer, EMBA, joined the work in September 1987, successively served as deputy director of the machine repair workshop of Jinhua cement factory and chief of technical department, deputy Director and Director of Jinsong Cement Plant, General Manager of Jianfeng Group Jinhua Jinma Cement Co., Ltd., General Manager of Zhejiang Jianfeng Cement Co., Ltd., Deputy General Manager of the Company, currently Director and General Manager of the Company, concurrently: Vice President of Zhejiang Cement Association.

2 , Zhu Jianwei resume: 1967# born in November 121, master of business administration, economist, joined the work in August 1991, successively served as the company's planning and development department, Shanghai office, securities management department, board of directors office staff, the company's board of directors secretary.

3 , Mr. Huang Jinlong: 1965# born in February 125, master's degree, professor-level senior engineer and licensed pharmacist. Joined the work in August 1988, served as the chief and deputy director of the quality inspection section and deputy director of Zhejiang Aotokang Pharmaceutical Co., Ltd., and the manager of the development department of Zhejiang Aotokang Pharmaceutical Group; joined the company in August 1998 and served as Zhejiang Jianfeng Pharmaceutical Co., Ltd. Product Development Manager, Assistant General Manager, Deputy General Manager, Executive Deputy General Manager, General Manager, and Deputy General Manager of the Company.

, Mr. Zhang Fengliang: 1977# born in October 129, graduate student, MBA, engineer. He joined the work in August 1999 and successively served as the main operation of the kiln in the manufacturing workshop of Zhejiang Jianfeng Jinma Cement Co., Ltd., the director of the manufacturing workshop of Zhejiang Jianfeng Dengcheng Cement Co., Ltd., and the deputy general manager and executive deputy general manager of Daye Jianfeng Cement Co., Ltd. General manager, deputy general manager of the company, concurrently vice chairman of Daye City Federation of Industry and Commerce, and vice chairman of Hubei Cement Association. 5

, Mr. Xiang Chongping: 1964# born in October 133, bachelor's degree, senior economist, enterprise legal consultant, human resources manager. He joined the work in December 1981 and served as deputy director of the office, vice chairman of the trade union, manager of the enterprise management department and director of the office of Jinhua Enterprise Building Co., Ltd. he joined the company in October 1997 and successively served as deputy manager and manager of the human resources department of the company, deputy general manager of the company, and vice president of Jinhua Trademark Federation.

6 , Mr. Lan Xiaolong: 1973# born in June 137, bachelor's degree, accountant. He joined the work in September 1997 and served as the financial clerk of the company, the financial manager of Jinhua Pharmaceutical Company, the deputy manager, manager and chief financial officer of the finance department of Zhejiang Jianfeng Pharmaceutical Co., Ltd., and the person in charge of finance of the company.

7 , Ms. Liu Lisu, born in April 141, 1971#, junior college, accountant title. He took part in the work in December 1991 and successively engaged in financial work in the finance department of Zhejiang Jianfeng Cement Co., Ltd., the finance department of Zhejiang Jianfeng Communication Cable Co., Ltd., the finance department of Zhejiang Jianfeng Pharmaceutical Co., Ltd., the sales department of Zhejiang Jianfeng Pharmaceutical Co., Ltd., and the finance department of Zhejiang Jianfeng Pharmaceutical Co., Ltd. He is currently the Director of the Audit Office of the Company.

, Mr. Zhou Hengbin, 1986# born in October 145, bachelor's degree. He joined the company in January 2010 and has worked in Zhejiang Jianfeng Pharmaceutical Co., Ltd. and the office of the board of directors of the company. He is currently the company's securities affairs representative.

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页